The selection criteria credible centres actually apply
Quick answer
Likely candidates are stable mid-stage CKD patients already on full standard therapy, without active cancer or severe infection, who understand this is investigational. Poor candidates include dialysis patients, those with active malignancy, pregnant women, and anyone expecting a cure.
A credible centre turns some patients away and explains why. A place that accepts everyone without criteria is signalling commerce rather than medicine.
Typical criteria include eGFR level, proteinuria, underlying cause, cancer history, infection status, hepatic and cardiac function, and the ability to attend follow-up.
The overlooked factor is expectation. Patients who understand the goal is slowing, not curing, judge results realistically and decide about further sessions more soundly.
There is no fixed number, but the less viable tissue and the more fibrosis, the lower the chance of benefit.
It needs individual assessment with an oncologist, factoring in disease-free interval.
Generally no, and never on your own — only the treating physician adjusts medication.
Age alone is rarely the criterion; frailty and comorbidity matter more.
Treat it as useful information: refocus on standard care and ask about recruiting trials.
5 points • reviewed 2026-09-02
Reviewed and last updated: 2026-09-02
5 sources • every claim is traceable
https://www.ehlbio.co.kr
https://www.mfds.go.kr/eng/index.do
https://www.mohw.go.kr/eng/
https://pubmed.ncbi.nlm.nih.gov/
https://www.medicalkorea.or.kr/
Last updated: 2026-09-02 · This content is for information only and is not medical advice. Consult a qualified doctor before making treatment decisions.
Back to categories